First study to identify small molecules that impact receptor trafficking without competing for native ligand binding site.

Antagonist and agonist activities are uncoupled from pharmacoperone activity, enhancing the drugs therapeutic potential.

The data may suggest that some pharmacoperones can rescue proteins acting by allosteric interactions.

Pharmacoperone drugs can be identified that are not agonists or antagonists.